Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Biscaglia

Showing results (41-50 of 180) with videos related to

Pageof 18
Sort By:
Pharmacological Research|April 8, 2015
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized studyGianluca Campo, Rita Pavasini, Simone Biscaglia, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 24, 2015
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trialGabriele Crimi, Sergio Leonardi, Francesco Costa, et al.
Journal of Interventional Cardiology|November 9, 2020
Angio-Based Index of Microcirculatory Resistance for the Assessment of the Coronary Resistance: A Proof of Concept StudyMatteo Tebaldi, Simone Biscaglia, Domenico Di Girolamo, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 13, 2016
Reperfusion Damage　- A Story of Success, Failure, and HopeRoberto Ferrari, Cristina Balla, Michele Malagù, et al.
Cardiovascular Drugs and Therapy|February 4, 2015
Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical managementGianluca Campo, Rita Pavasini, Michele Malagù, et al.
Cardiovascular Drugs and Therapy|June 9, 2022
Shedding Light on Treatment Options for Coronary Vasomotor Disorders: A Systematic ReviewFederico Marchini, Graziella Pompei, Emanuele D'Aniello, et al.
Journal of Thoracic Disease|September 13, 2017
The impact of the 3-year ABSORB II trial results on my clinical practice: an Italian surveyMatteo Serenelli, Simone Biscaglia, Elisabetta Tonet, et al.
European Heart Journal|April 24, 2014
Prospective validation of the Bleeding Academic Research Consortium classification in the all-comer PRODIGY trialPascal Vranckx, Sergio Leonardi, Matteo Tebaldi, et al.
JACC. Cardiovascular Interventions|November 10, 2022
Trans-Stent FFR Gradient as a Modifiable Integrant in Predicting Long-Term Target Vessel FailureBarry F Uretsky, Shiv Kumar Agarwal, Srikanth Vallurupalli, et al.
Journal of Clinical Medicine|February 25, 2022
Acetylcholine Use in Modern Cardiac Catheterization Laboratories: A Systematic ReviewAndrea Marrone, Rita Pavasini, Ennio Scollo, et al.
Pageof 18

Showing results (41-50 of 180) with videos related to

Sort By:
Pageof 18
Pharmacological Research|April 8, 2015
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized studyGianluca Campo, Rita Pavasini, Simone Biscaglia, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 24, 2015
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trialGabriele Crimi, Sergio Leonardi, Francesco Costa, et al.
Journal of Interventional Cardiology|November 9, 2020
Angio-Based Index of Microcirculatory Resistance for the Assessment of the Coronary Resistance: A Proof of Concept StudyMatteo Tebaldi, Simone Biscaglia, Domenico Di Girolamo, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 13, 2016
Reperfusion Damage　- A Story of Success, Failure, and HopeRoberto Ferrari, Cristina Balla, Michele Malagù, et al.
Cardiovascular Drugs and Therapy|February 4, 2015
Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical managementGianluca Campo, Rita Pavasini, Michele Malagù, et al.
Cardiovascular Drugs and Therapy|June 9, 2022
Shedding Light on Treatment Options for Coronary Vasomotor Disorders: A Systematic ReviewFederico Marchini, Graziella Pompei, Emanuele D'Aniello, et al.
Journal of Thoracic Disease|September 13, 2017
The impact of the 3-year ABSORB II trial results on my clinical practice: an Italian surveyMatteo Serenelli, Simone Biscaglia, Elisabetta Tonet, et al.
European Heart Journal|April 24, 2014
Prospective validation of the Bleeding Academic Research Consortium classification in the all-comer PRODIGY trialPascal Vranckx, Sergio Leonardi, Matteo Tebaldi, et al.
JACC. Cardiovascular Interventions|November 10, 2022
Trans-Stent FFR Gradient as a Modifiable Integrant in Predicting Long-Term Target Vessel FailureBarry F Uretsky, Shiv Kumar Agarwal, Srikanth Vallurupalli, et al.
Journal of Clinical Medicine|February 25, 2022
Acetylcholine Use in Modern Cardiac Catheterization Laboratories: A Systematic ReviewAndrea Marrone, Rita Pavasini, Ennio Scollo, et al.
Pageof 18